Hermes Investment Management Ltd. boosted its stake in West Pharmaceutical Services Inc. (NYSE:WST) by 0.8% during the first quarter, Holdings Channel reports. The institutional investor owned 949,801 shares of the medical instruments supplier’s stock after buying an additional 7,628 shares during the period. West Pharmaceutical Services comprises approximately 1.3% of Hermes Investment Management Ltd.’s portfolio, making the stock its 19th largest position. Hermes Investment Management Ltd. owned approximately 1.30% of West Pharmaceutical Services worth $77,513,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. LS Investment Advisors LLC raised its position in West Pharmaceutical Services by 2.0% in the third quarter. LS Investment Advisors LLC now owns 5,168 shares of the medical instruments supplier’s stock valued at $385,000 after buying an additional 100 shares in the last quarter. Advantus Capital Management Inc increased its stake in West Pharmaceutical Services by 1.1% in the third quarter. Advantus Capital Management Inc now owns 8,950 shares of the medical instruments supplier’s stock valued at $667,000 after buying an additional 100 shares during the last quarter. US Bancorp DE increased its stake in West Pharmaceutical Services by 3.9% in the third quarter. US Bancorp DE now owns 2,921 shares of the medical instruments supplier’s stock valued at $218,000 after buying an additional 110 shares during the last quarter. Suntrust Banks Inc. increased its stake in West Pharmaceutical Services by 1.8% in the third quarter. Suntrust Banks Inc. now owns 9,149 shares of the medical instruments supplier’s stock valued at $679,000 after buying an additional 166 shares during the last quarter. Finally, Ladenburg Thalmann Financial Services Inc. increased its stake in West Pharmaceutical Services by 7.7% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,945 shares of the medical instruments supplier’s stock valued at $250,000 after buying an additional 210 shares during the last quarter. Institutional investors and hedge funds own 90.31% of the company’s stock.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services Inc. (NYSE:WST) traded up 0.11% during midday trading on Friday, reaching $81.96. 228,126 shares of the company traded hands. The company has a 50-day moving average price of $80.95 and a 200-day moving average price of $81.01. The company has a market cap of $6.00 billion, a price-to-earnings ratio of 42.91 and a beta of 0.94. West Pharmaceutical Services Inc. has a 12-month low of $69.60 and a 12-month high of $88.30.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, February 16th. The medical instruments supplier reported $0.54 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.56 by $0.02. West Pharmaceutical Services had a return on equity of 14.54% and a net margin of 9.27%. The company had revenue of $382.30 million for the quarter, compared to the consensus estimate of $387.31 million. During the same quarter last year, the business posted $0.47 EPS. West Pharmaceutical Services’s quarterly revenue was up 6.3% on a year-over-year basis. On average, analysts predict that West Pharmaceutical Services Inc. will post $2.50 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 3rd. Shareholders of record on Wednesday, April 19th will be issued a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Monday, April 17th. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 28.11%.

TRADEMARK VIOLATION NOTICE: This news story was published by Financial Market News and is the property of of Financial Market News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at http://www.financial-market-news.com/hermes-investment-management-ltd-purchases-7628-shares-of-west-pharmaceutical-services-inc-wst/1406095/.

WST has been the subject of several research analyst reports. Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating and set a $97.00 price objective for the company in a report on Wednesday, January 11th. Jefferies Group LLC upped their price objective on shares of West Pharmaceutical Services from $76.00 to $82.00 and gave the stock a “hold” rating in a report on Tuesday, January 24th. Finally, Janney Montgomery Scott reaffirmed a “buy” rating on shares of West Pharmaceutical Services in a report on Friday, December 23rd.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

5 Day Chart for NYSE:WST

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.